Works about CELECOXIB

Results: 1308

Evaluation of drug-drug interaction potentials between JP-1366 and celecoxib using physiologically based pharmacokinetic modeling.

Published in:

Translational & Clinical Pharmacology, 2025, v. 33, n. 2, p. 90, doi. 10.12793/tcp.2025.33.e10

By:

Seung Chan Choi;
Kim, John;
Hyeong-Seok Lim

Publication type:

Article

Protective effect of celecoxib against capecitabine induced hand and foot syndrome in patients with colorectal Cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04794-5

By:

Kettana, Ahmed M.;
Mostafa, Tarek M.;
Ghannam, Amr A.;
El-Afify, Dalia R.

Publication type:

Article

Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.

Published in:

Liver International, 2010, v. 30, n. 7, p. 969, doi. 10.1111/j.1478-3231.2010.02256.x

By:

Chávez, Enrique;
Segovia, Jos;
Shibayama, Mineko;
Tsutsumi, Victor;
Vergara, Paula;
Castro-Sánchez, Luis;
Salazar, Eduardo Pérez;
Moreno, Mario G.;
Muriel, Pablo

Publication type:

Article

The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.

Published in:

Liver International, 2009, v. 29, n. 1, p. 25, doi. 10.1111/j.1478-3231.2008.01760.x

By:

Jun Yu;
Hui, Alex Y.;
Chu, Eagle S. H.;
Go, Minnie Y. Y.;
Cheung, Kin F.;
Wu, Chung W.;
Chan, Henry L. Y.;
Sung, Joseph J. Y.

Publication type:

Article

Effect of celecoxib on experimental liver fibrosis in rat.

Published in:

Liver International, 2006, v. 26, n. 1, p. 125, doi. 10.1111/j.1478-3231.2005.01202.x

By:

Hui, Alex Yui;
Wai Keung Leung;
Chan, Henry Lik Yuen;
Chan, Francis Ka Leung;
Minnie Yin Yin Go;
Ka Kui Chan;
Bao Dong Tang;
Chu, Eagle Siu Hong;
Sung, Joseph Jao Yiu

Publication type:

Article

A fast and green reversed‐phase HPLC method with fluorescence detection for simultaneous determination of amlodipine and celecoxib in their newly approved fixed‐dose combination tablets.

Published in:

Journal of Separation Science, 2020, v. 43, n. 16, p. 3197, doi. 10.1002/jssc.202000345

By:

Abdel Hamid, Mohamed A.;
Mabrouk, Mokhtar M.;
Michael, Mary A.

Publication type:

Article

Central composite design with the help of multivariate curve resolution in loadability optimization of RP-HPLC to scale-up a binary mixture.

Published in:

Journal of Separation Science, 2016, v. 39, n. 6, p. 1031, doi. 10.1002/jssc.201500526

By:

Taheri, Mohammadreza;
Moazeni‐Pourasil, Roudabeh Sadat;
Sheikh‐Olia‐Lavasani, Majid;
Karami, Ahmad;
Ghassempour, Alireza

Publication type:

Article

Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 2, p. 231, doi. 10.1007/s11060-017-2380-5

By:

Sato, Aya;
Mizobuchi, Yoshifumi;
Nakajima, Kohei;
Shono, Kenji;
Fujihara, Toshitaka;
Kageji, Teruyoshi;
Kitazato, Keiko;
Matsuzaki, Kazuhito;
Mure, Hideo;
Kuwayama, Kazuyuki;
Sumi, Akiko;
Saya, Hideyuki;
Sampetrean, Oltea;
Nagahirao, Shinji

Publication type:

Article

Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis.

Published in:

Journal of Neuro-Oncology, 2015, v. 124, n. 2, p. 265, doi. 10.1007/s11060-015-1834-x

By:

Welzel, Grit;
Gehweiler, Julian;
Brehmer, Stefanie;
Appelt, Jens-Uwe;
Deimling, Andreas;
Seiz-Rosenhagen, Marcel;
Schmiedek, Peter;
Wenz, Frederik;
Giordano, Frank

Publication type:

Article

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.

Published in:

Journal of Neuro-Oncology, 2011, v. 102, n. 2, p. 273, doi. 10.1007/s11060-010-0313-7

By:

Walbert, Tobias;
Gilbert, Mark;
Groves, Morris;
Puduvalli, Vinay;
Alfred Yung, W.;
Conrad, Charles;
Bobustuc, George;
Colman, Howard;
Hsu, Sigmund;
Nebiyou Bekele, B.;
Qiao, Wei;
Levin, Victor

Publication type:

Article

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2010, v. 100, n. 3, p. 407, doi. 10.1007/s11060-010-0192-y

By:

Stockhammer, Florian;
Misch, Martin;
Koch, Arend;
Czabanka, Marcus;
Plotkin, Michail;
Blechschmidt, Cristiane;
Tuettenberg, Jochen;
Vajkoczy, Peter

Publication type:

Article

Celecoxib decreases mitochondrial complex IV activity and induces oxidative stress in isolated rat heart mitochondria: An analysis for its cardiotoxic adverse effect.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 1, p. 1, doi. 10.1002/jbt.22934

By:

Atashbar, Saman;
Jamali, Zhaleh;
Khezri, Saleh;
Salimi, Ahmad

Publication type:

Article

Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 6, p. 1585, doi. 10.1007/s10067-023-06541-8

By:

Guo, Yanke;
Jiang, Dongbin;
Mai, Zhiyan;
Chen, Yufeng;
Li, Ting;
Gao, Guanmin

Publication type:

Article

Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.

Published in:

Clinical Rheumatology, 2014, v. 33, n. 10, p. 1415, doi. 10.1007/s10067-014-2719-7

By:

Park, Jin;
Park, Min-Chan;
Park, Yong-Beom;
Lee, Soo-Kon;
Lee, Sang-Won

Publication type:

Article

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.

Published in:

Clinical Rheumatology, 2006, v. 25, n. 1, p. 42, doi. 10.1007/s10067-005-1126-5

By:

Fleischmann, Roy;
Sheldon, Eric;
Maldonado-Cocco, José;
Dutta, Dipen;
Yu, Sue;
Sloan, Victor

Publication type:

Article

The renal effects of the addition of low-dose aspirin to COX-2 selective and nonselective antiinflammatory drugs.

Published in:

2006

By:

Pamuk, Ömer;
Necati &#00C7akır

Publication type:

Letter

Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial.

Published in:

Surgery Today, 2021, v. 51, n. 7, p. 1118, doi. 10.1007/s00595-020-02199-w

By:

Saito, Takuya;
Iwamoto, Shigeyoshi;
Murotani, Kenta;
Hashimoto, Atsushi;
Kurahashi, Shintaro;
Fukami, Yasuyuki;
Komatsu, Shunichiro;
Kaneko, Kenitiro;
Mishima, Hideyuki;
Sano, Tsuyoshi

Publication type:

Article

Postoperative analgesia using fentanyl plus celecoxib versus epidural anesthesia after laparoscopic colon resection.

Published in:

Surgery Today, 2017, v. 47, n. 2, p. 174, doi. 10.1007/s00595-016-1356-y

By:

Yoshida, Tadashi;
Homma, Shigenori;
Shibasaki, Susumu;
Shimokuni, Tatsushi;
Sakihama, Hideyasu;
Takahashi, Norihiko;
Kawamura, Hideki;
Taketomi, Akinobu

Publication type:

Article

Pharmacological inhibition of beta-catenin in hepatoblastoma cells.

Published in:

Pediatric Surgery International, 2013, v. 29, n. 2, p. 141, doi. 10.1007/s00383-012-3237-9

By:

Ellerkamp, V.;
Lieber, J.;
Nagel, C.;
Wenz, J.;
Warmann, S.;
Fuchs, J.;
Armeanu-Ebinger, S.

Publication type:

Article

Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents.

Published in:

Oncology, 2010, v. 77, n. 6, p. 358, doi. 10.1159/000275830

By:

Noberasco, Cristina;
Spitaleri, Gianluca;
Mancuso, Patrizia;
Zorzino, Laura;
Radice, Davide;
Milani, Alessandra;
Rocca, Andrea;
Bertolini, Francesco;
Sandri, Maria Teresa;
Curigliano, Giuseppe;
De Pas, Tommaso;
Jemos, Costantino;
Salè, Emanuela Omodeo;
Boselli, Sabrina;
De Braud, Filippo

Publication type:

Article

Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers.

Published in:

Oncology, 2009, v. 76, n. 4, p. 254, doi. 10.1159/000205388

By:

Pino, Maria S.;
Milella, Michele;
Gelibter, Alain;
Sperduti, Isabella;
De Marco, Salvatore;
Nuzzo, Carmen;
Bria, Emilio;
Carpanese, Livio;
Ruggeri, Enzo M.;
Carlini, Paolo;
Cognetti, Francesco

Publication type:

Article

Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: A network meta-analysis.

Published in:

Modern Rheumatology, 2018, v. 28, n. 6, p. 1021, doi. 10.1080/14397595.2018.1439694

By:

Sun-Young Jung;
Eun Jin Jang;
Seoung Wan Nam;
Hyuk Hee Kwon;
Seul Gi Im;
Dam Kim;
Soo-Kyung Cho;
Dalho Kim;
Yoon-Kyoung Sung

Publication type:

Article

Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.

Published in:

Modern Rheumatology, 2013, v. 23, n. 5, p. 934, doi. 10.3109/s10165-012-0772-0

By:

Takahashi, Daisuke;
Majima, Tokifumi;
Onodera, Tomohiro;
Kasahara, Yasuhiko;
Inoue, Masahiro;
Irie, Toru;
Kasemura, Toshiyuki

Publication type:

Article

Celecoxib, a cyclooxygenase-2 inhibitor, improved upper gastrointestinal lesions in rheumatoid arthritis patients as assessed by endoscopic evaluation.

Published in:

Modern Rheumatology, 2012, v. 22, n. 3, p. 353, doi. 10.3109/s10165-011-0524-6

By:

Tsuji, Shigeyoshi;
Miyoshi, Hirofumi;
Tomita, Tetsuya;
Nakase, Takanobu;
Hamada, Masayuki;
Oomae, Takahiro;
Tsumoto, Chikako;
Hirata, Yoshimasa;
Iguchi, Munetaka;
Edogawa, Shoko;
Kawai, Hideo;
Yoshikawa, Hideki

Publication type:

Article

A New Stability–Indicating RP-HPLC Method to Determine Assay and Known Impurity of Celecoxib API.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 8, p. 779, doi. 10.1080/03639040500216378

By:

Jadhav, A. S.;
Shingare, M. S.

Publication type:

Article

Enhanced In Vitro Percutaneous Absorption and In Vivo Anti-Inflammatory Effect of a Selective Cyclooxygenase Inhibitor Using Microemulsion.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 4/5, p. 405, doi. 10.1080/03639040500214605

By:

Subramanian, N.;
Ghosal, Saroj K.;
Moulik, S. P.

Publication type:

Article

Celecoxib-Cyclodextrin Systems: Characterization and Evaluation of In Vitro and In Vivo Advantage.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 2, p. 169, doi. 10.1081/DDC-200047795

By:

Nagarsenker, M. S.;
Joshi, M. S.

Publication type:

Article

Preparation and Characterization of Glassy Celecoxib.

Published in:

Drug Development & Industrial Pharmacy, 2003, v. 29, n. 7, p. 739, doi. 10.1081/DDC-120021773

By:

Paradkar, A. R.;
Chauhan, B.;
Yamamura, S.;
Pawar, A. P.

Publication type:

Article

Spherical Crystallization of Celecoxib.

Published in:

Drug Development & Industrial Pharmacy, 2002, v. 28, n. 10, p. 1213, doi. 10.1081/DDC-120015354

By:

Paradkar, A. R.;
Pawar, A. P.;
Chordiya, J. K.;
Patil, V. B.;
Ketkar, A. R.

Publication type:

Article

A Stability-Indicating HPLC Method to Determine Celecoxib in Capsule Formulations.

Published in:

Drug Development & Industrial Pharmacy, 2002, v. 28, n. 7, p. 815, doi. 10.1081/DDC-120005627

By:

Dhabu, Pramod M.;
Akamanchi, Krisnacharya G.

Publication type:

Article

Trends in Celecoxib Prescribing: A Single Institution 16-Month Review.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 8, p. 2823, doi. 10.3390/jcm14082823

By:

Cerda, Ivo H.;
Jung, Helen;
Guerrero, Maria C.;
Diez Tafur, Rodrigo;
Yong, Robert Jason;
Robinson, Christopher L.;
Hasoon, Jamal J.

Publication type:

Article

Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1036, doi. 10.3390/jcm14041036

By:

Park, Yong-Beom;
Kim, Jun-Ho

Publication type:

Article

Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6683, doi. 10.3390/jcm12206683

By:

Ahsan, Hina;
Malik, Shaukat Iqbal;
Shah, Fawad Ali;
El-Serehy, Hamed A.;
Ullah, Amin;
Shah, Zafar Abbas

Publication type:

Article

Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3497, doi. 10.3390/jcm12103497

By:

Gędek, Adam;
Szular, Zofia;
Antosik, Anna Z.;
Mierzejewski, Paweł;
Dominiak, Monika

Publication type:

Article

The Effect of Celecoxib on the Progression of Calcific Aortic Valve Disease—Protective or Pathogenic?

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2717, doi. 10.3390/jcm12072717

By:

Vinton, Zachary;
Wolfe, Kevin;
Fisher, Jensen;
Brooks, Amanda

Publication type:

Article

Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4560, doi. 10.3390/jcm11154560

By:

Tudor, Diana Valentina;
Florea, Adrian;
Cenariu, Mihai;
Olteanu, Diana Elena;
Farcaș, Marius;
Hopârtean, Andreea;
Clichici, Simona Valeria;
Filip, Gabriela Adriana

Publication type:

Article

Functional Status and Health-Related Quality of Life of Elderly Osteoarthritic Patients Treated With Celecoxib.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2001, v. 56, n. 3, p. M167, doi. 10.1093/gerona/56.3.M167

By:

Lisse, Jeffrey;
Espinoza, Luis

Publication type:

Article

Preparation and evaluation of electrospun nanofibers containing pectin and time-dependent polymers aimed for colonic drug delivery of celecoxib.

Published in:

Nanomedicine Journal, 2016, v. 3, n. 1, p. 43, doi. 10.7508/nmj.2016.01.005

By:

Akhgari, A.;
Rotubati, M. H.

Publication type:

Article

Assessment of Anti-Inflammatory Potential of Dayak Onion (Eleutherine bulbosa (Mill.) Urb.) Extract in Comparison to Celecoxib.

Published in:

2024

By:

Permana, Zuliar;
Zefrina, Normalita Faraz;
Kurniati, Neng Fisheri;
Insanu, Muhamad;
Mudhakir, Diky

Publication type:

Abstract

Celecoxib-loaded Nanoemulsion: Solubility of Celecoxib in Various Fractionated Medium Chain Triglycerides and Surfactants.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, p. 30

By:

Hairul, Nuriana Munirah;
Ibrahim, Salizatul Ilyana;
Anuar, Nor Khaizan;
Salim, Norazlinaliza;
Zulfakar, Mohd Hanif

Publication type:

Article

Effect of Preoperative Oral Celecoxib on Pain Reduction in Elective Patients for Leg Surgery.

Published in:

Zahedan Journal of Research in Medical Sciences, 2013, v. 15, n. 2, p. 83

By:

Dadras, Mohammad Mehdi;
Borjeian, Shahram;
Khoshfetrat, Masoum;
Dadras, Mohammad Amin

Publication type:

Article

Evaluation of Chemoprevention Effect of Systemic Celecoxib on Induction of Tongue Neoplasms in Rat.

Published in:

Zahedan Journal of Research in Medical Sciences, 2013, v. 15, n. 1, p. 1

By:

Arbabi-Kalati, Fateme;
Mesgari-Abbasi, Mehran;
Nasirinasab, Mojgan;
Sohrabi, Maryam;
Roshangar, Leila;
Soleimani, PJafar;
Khaki, Amir A.;
Doustar, Yousof;
JavadzadeP, Yousof

Publication type:

Article

Acoustic-like dynamics of amorphous drugs in the THz regime.

Published in:

Scientific Reports, 2013, p. 1, doi. 10.1038/srep02518

By:

Pogna, E. A. A.;
Rodríguez-Tinoco, C.;
Krisch, M.;
Rodríguez-Viejo, J.;
Scopigno, T.

Publication type:

Article

Celecoxib activates autophagy by inhibiting the mTOR signaling pathway and prevents apoptosis in nucleus pulposus cells.

Published in:

BMC Pharmacology & Toxicology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s40360-022-00633-y

By:

Chen, Weisin;
Yasen, Miersalijiang;
Wang, Hanquan;
Zhuang, Chenyang;
Wang, Zixiang;
Lu, Shunyi;
Jiang, Libo;
Lin, Hong

Publication type:

Article

Bioequivalence of Celecoxib Capsules in Chinese Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1069, doi. 10.1002/cpdd.1270

By:

Dong, Lichun;
Zhao, Mingxuan;
Huang, Huiyuan;
Guan, Runfang;
Li, Ruixia;
Fan, Yuxin;
Feng, Jin;
Zhang, Juan;
Zou, Wenhong;
Chen, Jiong;
Long, Shuxian;
He, Jianchang

Publication type:

Article

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.

Published in:

BJU International, 2004, v. 93, n. 3, p. 275, doi. 10.1111/j.1464-410X.2004.04601.x

By:

Pruthi, R. S.;
Derksen, J. E.;
Moore, D.

Publication type:

Article

Bleeding complications in patients on celecoxib and warfarin.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 5, p. 471, doi. 10.1111/j.1365-2710.2005.00676.x

By:

Chung, L.;
Chakravarty, E. F.;
Kearns, P.;
Wang, C.;
Bush, T. M.

Publication type:

Article

Adoption of celecoxib and rofecoxib: a nationwide database study.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 2, p. 145, doi. 10.1111/j.1365-2710.2005.00627.x

By:

Helin-Salmivaara, A.;
Huupponen, R.;
Virtanen, A.;
Klaukka, T.

Publication type:

Article

Macranthoidin B restrains the epithelial-mesenchymal transition through COX-2/PGE<sub>2</sub> pathway in endometriosis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1492098

By:

Ding, Yi;
Yang, Xiaoqian;
Wei, Qinghua;
Bi, Xuanming;
Zhang, Yuxin;
Ma, Yuxia;
Yang, Meisen;
Xu, Xiaoyu;
Li, Cong;
Wang, Qin;
Chen, Yi

Publication type:

Article

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1468579

By:

László, Szilvia B.;
Hutka, Barbara;
Tóth, András S.;
Hegyes, Tamás;
Demeter, Zsuzsanna O.;
Haghighi, Arezoo;
Wachtl, Gerda;
Kelemen, Ágnes;
Jakab, Anna;
Gyires, Klára;
Zádori, Zoltán S.

Publication type:

Article